BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12447824)

  • 1. [Experimental therapeutic models for fragile X syndrome].
    de Diego-Otero Y
    Rev Neurol; 2001 Oct; 33 Suppl 1():S70-6. PubMed ID: 12447824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered synaptic plasticity in a mouse model of fragile X mental retardation.
    Huber KM; Gallagher SM; Warren ST; Bear MF
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7746-50. PubMed ID: 12032354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome].
    Chiurazzi P; Neri G
    Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of the fragile X mental retardation protein, an RNA-binding protein.
    Khandjian EW
    Biochem Cell Biol; 1999; 77(4):331-42. PubMed ID: 10546896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragile X syndrome, the Fragile X related proteins, and animal models.
    Hoogeveen AT; Willemsen R; Oostra BA
    Microsc Res Tech; 2002 May; 57(3):148-55. PubMed ID: 12112450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fragile X syndrome: a model of gene-brain-behaviour relationships].
    Hagerman RJ; Hagerman PJ
    Rev Neurol; 2001 Oct; 33 Suppl 1():S51-7. PubMed ID: 12447820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells.
    Schrier M; Severijnen LA; Reis S; Rife M; van't Padje S; van Cappellen G; Oostra BA; Willemsen R
    Exp Neurol; 2004 Oct; 189(2):343-53. PubMed ID: 15380484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fragile X syndrome: from molecular genetics to neurobiology.
    Willemsen R; Oostra BA; Bassell GJ; Dictenberg J
    Ment Retard Dev Disabil Res Rev; 2004; 10(1):60-7. PubMed ID: 14994290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X syndrome.
    Terracciano A; Chiurazzi P; Neri G
    Am J Med Genet C Semin Med Genet; 2005 Aug; 137C(1):32-7. PubMed ID: 16010677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X mental retardation: misregulation of protein synthesis in the developing brain?
    Feng Y
    Microsc Res Tech; 2002 May; 57(3):145-7. PubMed ID: 12112449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology.
    Churchill JD; Beckel-Mitchener A; Weiler IJ; Greenough WT
    Microsc Res Tech; 2002 May; 57(3):156-8. PubMed ID: 12112451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.
    Koekkoek SK; Yamaguchi K; Milojkovic BA; Dortland BR; Ruigrok TJ; Maex R; De Graaf W; Smit AE; VanderWerf F; Bakker CE; Willemsen R; Ikeda T; Kakizawa S; Onodera K; Nelson DL; Mientjes E; Joosten M; De Schutter E; Oostra BA; Ito M; De Zeeuw CI
    Neuron; 2005 Aug; 47(3):339-52. PubMed ID: 16055059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets.
    Kaufmann WE; Cohen S; Sun HT; Ho G
    Microsc Res Tech; 2002 May; 57(3):135-44. PubMed ID: 12112448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X syndrome: from molecular genetics to therapy.
    D'Hulst C; Kooy RF
    J Med Genet; 2009 Sep; 46(9):577-84. PubMed ID: 19724010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif.
    Schaeffer C; Bardoni B; Mandel JL; Ehresmann B; Ehresmann C; Moine H
    EMBO J; 2001 Sep; 20(17):4803-13. PubMed ID: 11532944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of FMRP with ribosomal precursor particles in the nucleolus.
    Willemsen R; Bontekoe C; Tamanini F; Galjaard H; Hoogeveen A; Oostra B
    Biochem Biophys Res Commun; 1996 Aug; 225(1):27-33. PubMed ID: 8769090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of fragile X syndrome.
    Inoue SB; Siomi MC; Siomi H
    J Med Invest; 2000 Aug; 47(3-4):101-7. PubMed ID: 11019488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into Fragile X syndrome. Relating genotype to phenotype at the molecular level.
    Pozdnyakova I; Regan L
    FEBS J; 2005 Feb; 272(3):872-8. PubMed ID: 15670167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential translation and fragile X syndrome.
    Vanderklish PW; Edelman GM
    Genes Brain Behav; 2005 Aug; 4(6):360-84. PubMed ID: 16098135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.